Rite Aid to Open Additional COVID-19 On-Site Testing Locations in Coming Weeks
14 April 2020 - 03:30PM
Business Wire
Self-Swab Drive Through Tests to be Available
at Several Rite Aid Stores in Seven States Through Partnership with
White House Coronavirus Task Force
Today, Rite Aid (NYSE: RAD) announced plans to expand COVID-19
testing sites as part of its partnership with the White House
Coronavirus Task Force.
In addition to the current testing site in Philadelphia, Rite
Aid has added a new location, at a Rite Aid store located at 2604
Linglestown Road in Harrisburg, Pennsylvania. In coordination with
the U.S. Department of Health and Human Services (HHS), the company
expects to have additional drive-up COVID-19 testing locations open
soon at Rite Aid stores in Pennsylvania, New York, New Jersey,
Ohio, Michigan, Connecticut and Virginia.
All Rite Aid drive-up COVID-19 testing locations will utilize
self-swab nasal tests overseen by Rite Aid pharmacists. An online
platform will triage people based on guidelines established by the
Centers for Disease Control and Prevention (CDC), which can be
found here. The Harrisburg testing site will be open for testing 9
a.m.-5 p.m. seven days a week and expects to be able to conduct
approximately 200 tests each day.
The testing will take place in the store’s parking lot. As part
of the testing process, people must pre-register online and remain
in their vehicles from the time they arrive and until they
depart.
“Rite Aid is pleased to build on the success of our pilot site
in Philadelphia with a new COVID-19 testing location in Harrisburg.
We plan to have additional testing sites at stores across seven
states in the coming weeks,” said Heyward Donigan, President and
CEO, Rite Aid. “Through our partnership with the White House
Coronavirus Task Force, and with tremendous support from state and
local officials, we will significantly expand COVID-19 testing to
more than 5,000 tests daily in our country’s key hot spots when
fully operational. We are incredibly proud of the outstanding work
and commitment of all our Rite Aid associates both in our stores
and at the testing sites who are providing an important and
critical service to the communities we serve.”
Testing will be available at no cost to eligible individuals who
meet criteria established by the Centers for Disease Control and
Prevention. Patients are required to provide government issued
identification, be at least 18 years old and need to pre-register
online at www.riteaid.com in order to schedule a time slot for
testing.
Rite Aid will provide regular updates on the company’s progress
with COVID-19 testing.
About Rite Aid Corporation
Rite Aid Corporation is on the front lines of delivering
healthcare services and retail products to more than 1.6 million
Americans daily. Our pharmacists are uniquely positioned to engage
with customers and improve their health outcomes. We provide an
array of whole being health products and services for the entire
family through over 2,400 retail pharmacy locations across 18
states. Through EnvisionRxOptions, we provide pharmacy benefits and
services to approximately 4 million members nationwide. For more
information, www.riteaid.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200414005515/en/
MEDIA: Christopher Savarese (717) 975-5718
Rite Aid (NYSE:RAD)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
Von Mär 2023 bis Mär 2024